These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27695057)
1. The Expression and Prognostic Roles of MCMs in Pancreatic Cancer. Peng YP; Zhu Y; Yin LD; Zhang JJ; Guo S; Fu Y; Miao Y; Wei JS PLoS One; 2016; 11(10):e0164150. PubMed ID: 27695057 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer. Wu B; Xi S BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366 [TBL] [Abstract][Full Text] [Related]
3. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression. Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213 [TBL] [Abstract][Full Text] [Related]
4. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer. Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer. Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799 [TBL] [Abstract][Full Text] [Related]
6. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma. Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L Front Oncol; 2022; 12():1004324. PubMed ID: 36465369 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma. Liu K; Kang M; Liao X; Wang R PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040 [TBL] [Abstract][Full Text] [Related]
8. Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer. Guo JC; Li J; Zhao YP; Zhou L; Cui QC; Zhou WX; Zhang TP; You L PLoS One; 2015; 10(3):e0120332. PubMed ID: 25789763 [TBL] [Abstract][Full Text] [Related]
9. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance. Zhou L; Wang MY; Liang ZY; Zhou WX; You L; Pan BJ; Liao Q; Zhao YP Hum Pathol; 2016 Oct; 56():171-7. PubMed ID: 27346572 [TBL] [Abstract][Full Text] [Related]
10. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer. Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297 [No Abstract] [Full Text] [Related]
11. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma. Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415 [TBL] [Abstract][Full Text] [Related]
12. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma. Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821 [TBL] [Abstract][Full Text] [Related]
13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 in pancreatic cancer and its significance. Li XP; Zhang XW; Zheng LZ; Guo WJ Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555 [TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma. Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028 [TBL] [Abstract][Full Text] [Related]
16. MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication. Wang Y; Chen H; Zhang J; Cheng ASL; Yu J; To KF; Kang W Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188415. PubMed ID: 32822825 [TBL] [Abstract][Full Text] [Related]
17. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
18. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer. Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420 [TBL] [Abstract][Full Text] [Related]
19. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray. Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278 [TBL] [Abstract][Full Text] [Related]
20. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival. Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]